Epidemiology of sleep disorders during COVID-19 pandemic: A systematic scoping review

Tasnim, Samia; Rahman, Muhammad Imadur; Pawar, Priyanka; Chi, Xinli; Yu, Qian; Zou, Liye; Sultana, Abida; McKyer, E. Lisako J.; Ma, Ping; Hossain, Mahbub

doi:10.1101/2020.10.08.20209148

Cited by 28 publications

(21 citation statements)

References 97 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Recent studies have similarly shown that COVID-19 has affected mental health outcomes such as anxiety, depression, and post-traumatic stress symptoms [ 6 , 7 , 9 ]. Studies conducted in China in the early phase of COVID-19 found that the pandemic-affected individuals had a wide range of adverse psychological impacts of COVID-19 [ 21 , 22 , 23 , 24 , 25 ]. A recent meta-analysis by Salari et al., reported that the prevalence of stress 29.6%, the prevalence of anxiety 31.9%, and the prevalence of depression 33.7% globally [ 6 ].…”

Section: Introductionmentioning

confidence: 99%

Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis

Hossain

Rahman

Trisha

et al. 2021

Heliyon

Self Cite

View full text Add to dashboard Cite

Introduction The COVID-19 pandemic has impacted biopsychosocial health and wellbeing globally. Pre-pandemic studies suggest a high prevalence of common mental disorders, including anxiety and depression in South Asian countries, which may aggravate during this pandemic. This systematic meta-analytic review was conducted to estimate the pooled prevalence of anxiety and depression in South Asian countries during the COVID-19 pandemic. Method We systematically searched for cross-sectional studies on eight major bibliographic databases and additional sources up to October 12, 2020, that reported the prevalence of anxiety or depression in any of the eight South Asian countries. A random-effects model was used to calculate the pooled proportion of anxiety and depression. Results A total of 35 studies representing 41,402 participants were included in this review. The pooled prevalence of anxiety in 31 studies with a pooled sample of 28,877 was 41.3% (95% confidence interval [CI]: 34.7–48.1, I 2 = 99.18%). Moreover, the pooled prevalence of depression was 34.1% (95% CI: 28.9–39.4, I 2 = 99%) among 37,437 participants in 28 studies. Among the South Asian countries, India had a higher number of studies, whereas Bangladesh and Pakistan had a higher pooled prevalence of anxiety and depression. No studies were identified from Afghanistan, Bhutan, and Maldives. Studies in this review had high heterogeneity, high publication bias confirmed by Egger's test, and varying prevalence rates across sub-groups. Conclusion South Asian countries have high prevalence rates of anxiety and depression, suggesting a heavy psychosocial burden during this pandemic. Clinical and public mental health interventions should be prioritized alongside improving the social determinants of mental health in these countries. Lastly, a low number of studies with high heterogeneity requires further research exploring the psychosocial epidemiology during COVID-19, which may inform better mental health policymaking and practice in South Asia.

show abstract

Section: Introductionmentioning

confidence: 99%

Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis

Hossain

Rahman

Trisha

et al. 2021

Heliyon

Self Cite

View full text Add to dashboard Cite

show abstract

“…Recent studies have similarly shown that COVID-19 has affected mental health outcomes such as anxiety, depression, and post-traumatic stress symptoms 6,7,9 . Studies conducted in China in the early phase of COVID-19 found that the pandemic-affected individuals had a wide range of adverse psychological impacts of COVID-19 [21][22][23][24][25] . A recent meta-analysis by Salari et al, reported that the prevalence of stress 29.6%, the prevalence of anxiety 31.9%, and the prevalence of depression 33.7% globally 6 .…”

Section: Introductionmentioning

confidence: 99%

Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis

Hossain¹,

Rahman²,

Trisha³

et al. 2020

Preprint

Self Cite

View full text Add to dashboard Cite

Introduction: The COVID-19 pandemic has impacted biopsychosocial health and wellbeing globally. Pre-pandemic studies suggest a high prevalence of common mental disorders, including anxiety and depression in South Asian countries, which may aggravate during this pandemic. This systematic meta-analytic review was conducted to estimate the pooled prevalence of anxiety and depression in South Asian countries during the COVID-19 pandemic. Method: We systematically searched for cross-sectional studies on eight major bibliographic databases and additional sources up to October 12, 2020, that reported the prevalence of anxiety or depression in any of the eight South Asian countries. A random-effects model was used to calculate the pooled proportion of anxiety and depression. Results: A total of 35 studies representing 41,402 participants were included in this review. The pooled prevalence of anxiety in 31 studies with a pooled sample of 28,877 was 41.3% (95% confidence interval [CI]: 34.7-48.1, I2 = 99.18%). Moreover, the pooled prevalence of depression was 34.1% (95% CI: 28.9-39.4, I2 = 99%) among 37,437 participants in 28 studies. Among the South Asian countries, India had a higher number of studies, whereas Bangladesh and Pakistan had a higher pooled prevalence of anxiety and depression. No studies were identified from Afghanistan, Bhutan, and Maldives. Studies in this review had high heterogeneity and varying prevalence across sub-groups. Conclusion: South Asian countries have high prevalence rates of anxiety and depression, suggesting a heavy psychosocial burden during this pandemic. Clinical and public mental health interventions should be prioritized alongside improving the social determinants of mental health in these countries. Lastly, a low number of studies with high heterogeneity requires further research exploring the psychosocial epidemiology during COVID-19, which may inform better mental health policymaking and practice in South Asia.

show abstract

“…After the COVID-19 outbreak inception, the prevalence of insomnia is increasingly observed [ 26 ]. Ranging from 2.3 to 76.6%, with a pooled prevalence of 35.7%, insomnia is identified by a systematic review of a total of 78 studies [ 28 ], whereas the rate is found to be within 18–46.3% in Bangladesh [ 9 ]. The largest population-based study of the country reported 30.4%, 13.1%, and 2.8% rates of sub-threshold, moderate, and severe forms of insomnia, respectively, where the overall insomniac problem was 36.4% in that study [ 18 ].…”

Section: Discussionmentioning

confidence: 99%

Insomnia in Bangladeshi Young Adults During the COVID-19 Pandemic: The Role of Behavioral Factors, COVID-19 Risk and Fear, and Mental Health Issues

et al. 2021

View full text Add to dashboard Cite

Background Given the importance of sleep, several studies were conducted during the first wave of the COVID-19 pandemic in Bangladesh, but no study was conducted during the second wave. Thus, this study assessed the prevalence rate, associated factors, and predictive models of insomnia during the second wave of the COVID-19 pandemic. Methods An online-based cross-sectional survey was conducted during the second wave of the pandemic (within April 1–13, 2021) and collected information on sociodemographic, behavior and health, COVID-19 risk, fear of COVID-19, depression, anxiety, suicidality, and insomnia. A total of 756 data from Bangladeshi young adults (22.24 ± 4.39 years) were finally analyzed. Results About 13% of the participants ( n = 98 out of a total of 756) had the symptoms of insomnia. Insomnia had a significant gender difference, where females were more prone to be insomniac. Besides, middle class, urban residence, smoking status, not engaging in physical exercise, poor health status, and multi-comorbidities were also profoundly associated with insomnia. In addition, fear of COVID-19, COVID-19 risk, and mental health problems (i.e., depression, anxiety, and suicidality) showed a significant relationship in terms of insomnia. A total of 31.2% variance predicting insomnia was identified considering all of the studied variables. Conclusions The prevalence of insomnia reported herein seems relatively lower than the prior studies, but this figure is not neglectable. Thus, the identified associated factors are highly suggested to consider in policy actions with a special focus on mental health problems to elevate the risk of sleep problems.

show abstract

Epidemiology of sleep disorders during COVID-19 pandemic: A systematic scoping review

Cited by 28 publications

References 97 publications

Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis

Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis

Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis

Insomnia in Bangladeshi Young Adults During the COVID-19 Pandemic: The Role of Behavioral Factors, COVID-19 Risk and Fear, and Mental Health Issues

Contact Info

Product

Resources

About